share_log
Reuters ·  01/08 01:55

Evergreen Nephrology - Funding Was Led by Rubicon Founders, Oak Hc/FT and Group of Existing Investors, With Addition of K2 Healthventures

常青肾脏科 - 融资由Rubicon创办人、Oak Hc/Ft以及一组现有投资者主导,并增加了K2 Healthventures的投资。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发